284 related articles for article (PubMed ID: 25421478)
1. Biochemical characterization of recombinant Enterovirus 71 3C protease with fluorogenic model peptide substrates and development of a biochemical assay.
Shang L; Zhang S; Yang X; Sun J; Li L; Cui Z; He Q; Guo Y; Sun Y; Yin Z
Antimicrob Agents Chemother; 2015 Apr; 59(4):1827-36. PubMed ID: 25421478
[TBL] [Abstract][Full Text] [Related]
2. Identification and biochemical characterization of DC07090 as a novel potent small molecule inhibitor against human enterovirus 71 3C protease by structure-based virtual screening.
Ma GH; Ye Y; Zhang D; Xu X; Si P; Peng JL; Xiao YL; Cao RY; Yin YL; Chen J; Zhao LX; Zhou Y; Zhong W; Liu H; Luo XM; Chen LL; Shen X
Eur J Med Chem; 2016 Nov; 124():981-991. PubMed ID: 27776325
[TBL] [Abstract][Full Text] [Related]
3. Peptidomimetic ethyl propenoate covalent inhibitors of the enterovirus 71 3C protease: a P2-P4 study.
Ang MJ; Lau QY; Ng FM; Then SW; Poulsen A; Cheong YK; Ngoh ZX; Tan YW; Peng J; Keller TH; Hill J; Chu JJ; Chia CS
J Enzyme Inhib Med Chem; 2016; 31(2):332-9. PubMed ID: 25792507
[TBL] [Abstract][Full Text] [Related]
4. Structure of the Enterovirus 71 3C Protease in Complex with NK-1.8k and Indications for the Development of Antienterovirus Protease Inhibitor.
Wang Y; Cao L; Zhai Y; Yin Z; Sun Y; Shang L
Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28461310
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of enterovirus 71 replication and viral 3C protease by quercetin.
Yao C; Xi C; Hu K; Gao W; Cai X; Qin J; Lv S; Du C; Wei Y
Virol J; 2018 Jul; 15(1):116. PubMed ID: 30064445
[TBL] [Abstract][Full Text] [Related]
6. Antiviral activities of peptide-based covalent inhibitors of the Enterovirus 71 3C protease.
Tan YW; Ang MJ; Lau QY; Poulsen A; Ng FM; Then SW; Peng J; Hill J; Hong WJ; Chia CS; Chu JJ
Sci Rep; 2016 Sep; 6():33663. PubMed ID: 27645381
[TBL] [Abstract][Full Text] [Related]
7. Luteoloside Acts as 3C Protease Inhibitor of Enterovirus 71 In Vitro.
Cao Z; Ding Y; Ke Z; Cao L; Li N; Ding G; Wang Z; Xiao W
PLoS One; 2016; 11(2):e0148693. PubMed ID: 26870944
[TBL] [Abstract][Full Text] [Related]
8. Optimize the interactions at S4 with efficient inhibitors targeting 3C proteinase from enterovirus 71.
Zhang L; Huang G; Cai Q; Zhao C; Tang L; Ren H; Li P; Li N; Huang J; Chen X; Guan Y; You H; Chen S; Li J; Lin T
J Mol Recognit; 2016 Nov; 29(11):520-527. PubMed ID: 27185390
[TBL] [Abstract][Full Text] [Related]
9. Peptidyl aldehyde NK-1.8k suppresses enterovirus 71 and enterovirus 68 infection by targeting protease 3C.
Wang Y; Yang B; Zhai Y; Yin Z; Sun Y; Rao Z
Antimicrob Agents Chemother; 2015 May; 59(5):2636-46. PubMed ID: 25691647
[TBL] [Abstract][Full Text] [Related]
10. 4-Iminooxazolidin-2-One as a Bioisostere of Cyanohydrin Suppresses EV71 Proliferation by Targeting 3C
Xu B; Liu M; Ma S; Ma Y; Liu S; Shang L; Zhu C; Ye S; Wang Y
Microbiol Spectr; 2021 Dec; 9(3):e0102521. PubMed ID: 34787443
[TBL] [Abstract][Full Text] [Related]
11. Reversible covalent inhibitors suppress enterovirus 71 infection by targeting the 3C protease.
Liu M; Xu B; Ma Y; Shang L; Ye S; Wang Y
Antiviral Res; 2021 Aug; 192():105102. PubMed ID: 34082057
[TBL] [Abstract][Full Text] [Related]
12. A 3C(pro)-dependent bioluminescence imaging assay for in vivo evaluation of anti-enterovirus 71 agents.
Guo Z; Zhong X; Lin L; Wu S; Wang T; Chen Y; Zhai X; Wang Y; Wu H; Tong L; Han Y; Pan B; Peng Y; Si X; Zhang F; Zhao W; Zhong Z
Antiviral Res; 2014 Jan; 101():82-92. PubMed ID: 24263113
[TBL] [Abstract][Full Text] [Related]
13. A Novel Enterovirus 71 (EV71) Virulence Determinant: The 69th Residue of 3C Protease Modulates Pathogenicity.
Li B; Yue Y; Zhang Y; Yuan Z; Li P; Song N; Lin W; Liu Y; Gu L; Meng H
Front Cell Infect Microbiol; 2017; 7():26. PubMed ID: 28217559
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human enterovirus 71 3C protease.
Cui S; Wang J; Fan T; Qin B; Guo L; Lei X; Wang J; Wang M; Jin Q
J Mol Biol; 2011 May; 408(3):449-61. PubMed ID: 21396941
[TBL] [Abstract][Full Text] [Related]
15. 3C protease of enterovirus 68: structure-based design of Michael acceptor inhibitors and their broad-spectrum antiviral effects against picornaviruses.
Tan J; George S; Kusov Y; Perbandt M; Anemüller S; Mesters JR; Norder H; Coutard B; Lacroix C; Leyssen P; Neyts J; Hilgenfeld R
J Virol; 2013 Apr; 87(8):4339-51. PubMed ID: 23388726
[TBL] [Abstract][Full Text] [Related]
16. Susceptibility of inhibitors against 3C protease of coxsackievirus A16 and enterovirus A71 causing hand, foot and mouth disease: A molecular dynamics study.
Jetsadawisut W; Nutho B; Meeprasert A; Rungrotmongkol T; Kungwan N; Wolschann P; Hannongbua S
Biophys Chem; 2016 Dec; 219():9-16. PubMed ID: 27668727
[TBL] [Abstract][Full Text] [Related]
17. The Function and Mechanism of Enterovirus 71 (EV71) 3C Protease.
Wen W; Qi Z; Wang J
Curr Microbiol; 2020 Sep; 77(9):1968-1975. PubMed ID: 32556480
[TBL] [Abstract][Full Text] [Related]
18. Enterovirus 71 3C Promotes Apoptosis through Cleavage of PinX1, a Telomere Binding Protein.
Li J; Yao Y; Chen Y; Xu X; Lin Y; Yang Z; Qiao W; Tan J
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847364
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir and their substrates and anti-hand, foot, and mouth disease virus drug design.
Lu G; Qi J; Chen Z; Xu X; Gao F; Lin D; Qian W; Liu H; Jiang H; Yan J; Gao GF
J Virol; 2011 Oct; 85(19):10319-31. PubMed ID: 21795339
[TBL] [Abstract][Full Text] [Related]
20. Sumoylation-promoted enterovirus 71 3C degradation correlates with a reduction in viral replication and cell apoptosis.
Chen SC; Chang LY; Wang YW; Chen YC; Weng KF; Shih SR; Shih HM
J Biol Chem; 2011 Sep; 286(36):31373-84. PubMed ID: 21784861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
